BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Policy

  Laevoroc Immunology Announces FDA Orphan Drug Designation Granted to LR 09, a Novel Metabolic Immune Checkpoint Inhibitor for the Treatment of Leukemia Relapse after Allogeneic Stem Cell Transplant

  Laevoroc Immunology announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation for LR 09, a novel metabolic immune checkpoint inhibitor, for the treatment of patients with haematological malignancies who are diagnosed with a relapse after allogeneic stem cell transplant.

  February 28, 2023

   · 

  4 min read
• Business

  HUTCHMED Reports 2022 Full Year Results and Provides Business Updates

  HUTCHMED Limited reports its financial results for the year ended December 31, 2022 and provides updates on key clinical and commercial developments.

  February 28, 2023

   · 

  35 min read
• BioMidwest

  Rockwell Medical Named ‘Great Place to Work’

  Rockwell Medical, Inc. announced that it has been certified as a Great Place to Work® in 2023, the Company’s inaugural year participating in the accreditation.

  February 28, 2023

   · 

  3 min read
• Bio NC

  Milestone Pharmaceuticals to Present at Upcoming March 2023 Investor Conferences

  Milestone Pharmaceuticals Inc. announced that members of its management team will present at the following investor conferences.

  February 28, 2023

   · 

  1 min read
• Business

  Dentsply Sirona Reports Fourth Quarter and Full Year 2022 Results, Provides Full Year 2023 Outlook

  DENTSPLY SIRONA Inc. announced its financial results for the fourth quarter and full year 2022.

  February 28, 2023

   · 

  32 min read
• Business

  SpringWorks Therapeutics Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Business Highlights

  SpringWorks Therapeutics, Inc. reported financial results for the fourth quarter and full-year periods ended December 31, 2022 and provided an update on recent company developments.

  February 28, 2023

   · 

  14 min read
• Business

  Clover Health Reports Fourth Quarter and Full Year 2022 Financial Results

  Clover Health Investments, Corp. today reported financial results for the fourth quarter and full year 2022.

  February 28, 2023

   · 

  22 min read
• Business

  Mallinckrodt plc Reports Fourth Quarter and Fiscal 2022 Financial Results and Provides 2023 Guidance

  Mallinckrodt plc (NYSE American: MNK) (“Mallinckrodt” or the “Company”), a global specialty pharmaceutical company, today reported results for the fourth quarter ended December 30, 2022.

  February 28, 2023

   · 

  36 min read